持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/07/26 | 4,700 | 4,700 | 4,635 | 4,655 | +5 | +0.1% | 45,900 |
2019/07/25 | 4,655 | 4,670 | 4,625 | 4,650 | ±0 | ±0% | 44,800 |
2019/07/24 | 4,675 | 4,675 | 4,615 | 4,650 | -15 | -0.3% | 57,800 |
2019/07/23 | 4,650 | 4,685 | 4,620 | 4,665 | ±0 | ±0% | 39,500 |
2019/07/22 | 4,675 | 4,740 | 4,650 | 4,665 | -50 | -1.1% | 44,600 |
2019/07/19 | 4,620 | 4,720 | 4,610 | 4,715 | +95 | +2.1% | 48,600 |
2019/07/18 | 4,735 | 4,735 | 4,605 | 4,620 | -145 | -3% | 59,800 |
2019/07/17 | 4,730 | 4,785 | 4,720 | 4,765 | +25 | +0.5% | 39,200 |
2019/07/16 | 4,735 | 4,760 | 4,710 | 4,740 | -45 | -0.9% | 32,400 |
2019/07/12 | 4,765 | 4,790 | 4,715 | 4,785 | -5 | -0.1% | 30,400 |
2019/07/11 | 4,735 | 4,820 | 4,735 | 4,790 | +85 | +1.8% | 50,200 |
2019/07/10 | 4,680 | 4,720 | 4,635 | 4,705 | +5 | +0.1% | 53,800 |
2019/07/09 | 4,785 | 4,805 | 4,685 | 4,700 | -50 | -1.1% | 48,800 |
2019/07/08 | 4,830 | 4,835 | 4,745 | 4,750 | -100 | -2.1% | 41,800 |
2019/07/05 | 4,925 | 4,925 | 4,815 | 4,850 | -40 | -0.8% | 28,400 |
2019/07/04 | 4,880 | 4,940 | 4,850 | 4,890 | +50 | +1% | 31,800 |
2019/07/03 | 4,830 | 4,910 | 4,830 | 4,840 | -35 | -0.7% | 58,500 |
2019/07/02 | 4,800 | 4,890 | 4,795 | 4,875 | +115 | +2.4% | 47,100 |
2019/07/01 | 4,670 | 4,775 | 4,665 | 4,760 | +175 | +3.8% | 56,700 |
2019/06/28 | 4,680 | 4,700 | 4,565 | 4,585 | -50 | -1.1% | 63,400 |
2019/06/27 | 4,655 | 4,655 | 4,595 | 4,635 | -10 | -0.2% | 42,200 |
2019/06/26 | 4,710 | 4,725 | 4,640 | 4,645 | -60 | -1.3% | 52,000 |
2019/06/25 | 4,735 | 4,800 | 4,705 | 4,705 | -40 | -0.8% | 46,700 |
2019/06/24 | 4,630 | 4,760 | 4,630 | 4,745 | +130 | +2.8% | 51,900 |
2019/06/21 | 4,750 | 4,750 | 4,610 | 4,615 | -150 | -3.1% | 98,000 |
2019/06/20 | 4,775 | 4,835 | 4,765 | 4,765 | ±0 | ±0% | 48,500 |
2019/06/19 | 4,745 | 4,780 | 4,720 | 4,765 | +40 | +0.8% | 84,600 |
2019/06/18 | 4,750 | 4,825 | 4,725 | 4,725 | -15 | -0.3% | 52,900 |
2019/06/17 | 4,785 | 4,820 | 4,735 | 4,740 | -80 | -1.7% | 40,300 |
2019/06/14 | 4,805 | 4,845 | 4,755 | 4,820 | +15 | +0.3% | 50,000 |
2019/06/13 | 4,830 | 4,855 | 4,760 | 4,805 | -65 | -1.3% | 56,000 |
2019/06/12 | 4,845 | 4,915 | 4,815 | 4,870 | -10 | -0.2% | 43,900 |
2019/06/11 | 4,965 | 4,965 | 4,845 | 4,880 | -100 | -2% | 57,500 |
2019/06/10 | 4,960 | 5,000 | 4,935 | 4,980 | +110 | +2.3% | 42,900 |
2019/06/07 | 4,850 | 4,890 | 4,790 | 4,870 | -10 | -0.2% | 55,500 |
2019/06/06 | 4,865 | 4,950 | 4,840 | 4,880 | -5 | -0.1% | 48,200 |
2019/06/05 | 4,885 | 4,890 | 4,790 | 4,885 | +35 | +0.7% | 78,600 |
2019/06/04 | 4,880 | 4,910 | 4,805 | 4,850 | +5 | +0.1% | 52,200 |
2019/06/03 | 4,865 | 4,880 | 4,790 | 4,845 | -115 | -2.3% | 57,400 |
2019/05/31 | 4,990 | 5,020 | 4,950 | 4,960 | -70 | -1.4% | 47,600 |
2019/05/30 | 5,100 | 5,120 | 4,990 | 5,030 | -150 | -2.9% | 47,800 |
2019/05/29 | 5,220 | 5,260 | 5,130 | 5,180 | -150 | -2.8% | 54,700 |
2019/05/28 | 5,370 | 5,380 | 5,300 | 5,330 | -30 | -0.6% | 67,400 |
2019/05/27 | 5,350 | 5,380 | 5,300 | 5,360 | +40 | +0.8% | 34,700 |
2019/05/24 | 5,270 | 5,330 | 5,240 | 5,320 | +70 | +1.3% | 36,200 |
2019/05/23 | 5,200 | 5,280 | 5,150 | 5,250 | +60 | +1.2% | 36,100 |
2019/05/22 | 5,230 | 5,260 | 5,170 | 5,190 | -40 | -0.8% | 31,800 |
2019/05/21 | 5,240 | 5,290 | 5,210 | 5,230 | ±0 | ±0% | 30,200 |
2019/05/20 | 5,280 | 5,310 | 5,220 | 5,230 | -40 | -0.8% | 34,500 |
2019/05/17 | 5,150 | 5,290 | 5,130 | 5,270 | +120 | +2.3% | 53,800 |
1401~
1450
件表示中 / 3684件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 304,500円 | +3.0% | +27.5% | 2.63% | 19.28倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
東和薬品 | 252,400円 | +15.0% | -7.3% | 2.77% | 8.28倍 | 0.78倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 231,200円 | +14.2% | +41.0% | 1.99% | 11.32倍 | 1.15倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 218,100円 | +21.7% | +999.9% | 0.00% | 9.08倍 | 3.00倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム